Skip to main content

Table 5 Clinical correlation analysis between 10 prognostic GRGs, riskscore and clinical features

From: A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma

id

age

gender

race

grade

stage

T

M

N

ANKZF1

−0.511 (0.610)

0.375 (0.708)

5.65 (0.059)

−2.764 (0.006)

−3.114 (0.002)

−2.766 (0.006)

−3.05 (0.003)

−0.075 (0.940)

CD44

−0.342 (0.733)

−2.495 (0.013)

4.916 (0.086)

−2.216 (0.027)

− 2.172 (0.031)

− 2.268 (0.024)

−1.832 (0.070)

0.795 (0.427)

CHST6

−1.198 (0.233)

−0.024 (0.981)

5.346 (0.069)

−1.743 (0.082)

−1.794 (0.074)

−1.872 (0.063)

0.193 (0.847)

0.581 (0.561)

HS6ST2

−0.236 (0.814)

1.4 (0.163)

1.036 (0.596)

0.206 (0.837)

−0.313 (0.755)

−0.593 (0.554)

− 0.12 (0.905)

−0.394 (0.694)

IDUA

−0.556 (0.579)

1.105 (0.270)

13.523 (0.001)

−4.243 (2.673e-05)

−4.079 (5.649e-05)

−3.349 (9.142e-04)

−3.78 (2.389e-04)

−0.132 (0.895)

KIF20A

−0.84 (0.402)

−2.636 (0.009)

16.433 (2.701e-04)

−5.354 (1.566e-07)

−4.874 (1.993e-06)

− 4.542 (9.366e-06)

− 2.609 (0.010)

− 0.112 (0.911)

NDST3

−0.454 (0.650)

− 0.447 (0.655)

0.183 (0.912)

−2.118 (0.035)

−1.423 (0.156)

− 1.434 (0.153)

− 1.32 (0.189)

2.511 (0.013)

PLOD2

0.171 (0.865)

−2.622 (0.009)

9.262 (0.010)

−2.86 (0.004)

−4.439 (1.319e-05)

−4.286 (2.663e-05)

−2.177 (0.031)

1.353 (0.177)

VCAN

−0.054 (0.957)

−2.013 (0.045)

5.449 (0.066)

−1.422 (0.156)

−1.507 (0.133)

− 1.453 (0.147)

−0.316 (0.752)

0.947 (0.344)

FBP1

1.325 (0.186)

4.761 (3.75e-06)

5.32 (0.070)

3.295 (0.001)

3.412 (7.026e-04)

3.303 (0.001)

0.967 (0.335)

0.976 (0.330)

riskScore

−1.338 (0.183)

−1.399 (0.163)

0.705 (0.703)

−2.178 (0.030)

− 2.111 (0.036)

− 2.048 (0.042)

−0.851 (0.396)

−0.655 (0.513)